Patents Assigned to Sowakai Medical Foundation
  • ANTI-MEFLIN ANTIBODY FOR USE IN TREATMENT OF CANCER IN SUBJECT HAVING CANCER, AND PHARMACEUTICAL COMPOSITION COMPRISING THE ANTIBODY
    Publication number: 20230084099
    Abstract: An anti-MEFLIN antibody and a pharmaceutical composition comprising the antibody is described. The pharmaceutical composition may comprise an antibody-drug conjugate (ADC) of the anti-MEFLIN antibody and a cytotoxic agent, which may be connected to each other by a linker. The pharmaceutical composition may be used in the treatment of a cancer in a subject.
    Type: Application
    Filed: February 3, 2021
    Publication date: March 16, 2023
    Applicants: National University Corporation Tokai National Higher Education and Research System, Sowakai Medical Foundation
    Inventors: Atsushi ENOMOTO, Nobutoshi ESAKI, Masahide TAKAHASHI, Yuki MIYAI, Ryota ANDO, Yukihiro SHIRAKI, Yoshihiro NISHIDA, Makoto MATSUYAMA, Shino MANABE